Frontage Holdings Corporation (FGHQF)

OTCMKTS · Delayed Price · Currency is USD

0.1750

-0.0251 (-12.54%)

At close: Sep 4, 2026

Market Cap	286.54M -15.5%
Revenue (ttm)	278.30M +10.0%
Net Income	10.62M +176.9%
EPS	0.01 +174.7%
Shares Out	n/a
PE Ratio	26.98
Forward PE	11.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,000
Open	0.1750
Previous Close	0.2001
Day's Range	0.1750 - 0.1750
52-Week Range	0.1100 - 0.2001
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Frontage Holdings

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such a... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Employees 1,800

Stock Exchange OTCMKTS

Ticker Symbol FGHQF

Financial Performance

In 2025, Frontage Holdings's revenue was $256.69 million, an increase of 0.70% compared to the previous year's $254.91 million. Earnings were $6.79 million, an increase of 758.79%.

Financial Statements